A Phase II, Randomized, Double-blind, Placebo-controlled study to examine the effects of DAS181 in immunocompromised subjects with Lower Respiratory Tract Parainfluenza - Regional Cancer Care Associates LLC

Clinical Trials

A Phase II, Randomized, Double-blind, Placebo-controlled study to examine the effects of DAS181 in immunocompromised subjects with Lower Respiratory Tract Parainfluenza

Type of Cancer
Lung
Locations
Hackensack
Sponsor
Ansun Biopharma
Protocol Number
DAS181-2-05
Cancer Diagnosis
To Learn More Call
201-510-0910